Significant Cost Savings in Operating Expenses
Operating expenses were $3.9 million, a 24% improvement over last year's third quarter.
Successful Capital Raise
Completed a $3.9 million private investment in public equity (PIPE) transaction, providing financial strength for growth.
High Double-Digit New Client Deals
Secured high double-digit new client deals for January 1, indicating substantial increase in base business.
Operational and Technological Improvements
Consolidating claims processing into a single system to unlock cost savings and improve efficiency.
MarpaiRx Program Success
MarpaiRx program is a differentiating factor in winning new business, enhancing competitiveness.